Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Country / region: Switzerland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20131
20171
20181
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Genentech, Inc.1
Ipsen1
MedImmune LLC1
Merck KGaA, Darmstadt, Germany1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Pfizer1
Philogen S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis9
Colorectal Neoplasms3
Neoplasms2
Adenocarcinoma of Lung1
Bone Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Head and Neck Neoplasms1
Lymphoma, B-Cell1
Lymphoma, Non-Hodgkin1
Melanoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.